Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

VGX-3100 and Electroporation in Treating Patients With HIV-Positive High-Grade Anal Lesions

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03603808
Recruitment Status : Recruiting
First Posted : July 27, 2018
Last Update Posted : February 25, 2021
Sponsor:
Collaborators:
National Cancer Institute (NCI)
The Emmes Company, LLC
University of Arkansas
University of California, Los Angeles
AIDS and Cancer Specimen Resource
Inovio Pharmaceuticals
Information provided by (Responsible Party):
AIDS Malignancy Consortium

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : August 21, 2022
Estimated Study Completion Date : August 21, 2022